MET and renal cell carcinoma: Although more than ten germline alterations (VHL, MET, FLCN, FH, etc) are associated with a strong risk of RCC, they collectively cannot account for the twofold increased risk of RCC seen in first-degree relatives of RCC patients [8, 9].